Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This is a forecasted NIH small-business opportunity, the Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 SBIR, clinical trial optional), intended to help new entrepreneurs tra…
- Deadline
- Not specified
- Posted
- May 27, 2026
- Award amount
- Amount not specified
In plain English
This is a forecasted NIH small-business opportunity, the Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 SBIR, clinical trial optional), intended to help new entrepreneurs transition into small-business research. Eligibility, funding amount, and deadline are not yet published, so it is not currently open. SBIR awards are limited to U.S. small businesses meeting size and ownership requirements and typically exclude foreign firms; review the full notice of funding opportunity for exact eligibility.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from National Institutes of Health — soonest deadline first.
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health · Amount varies · Due Nov 10, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 3 days
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
National Institutes of Health · Up to $250K · Due in 8 days
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due in 8 days
Also listed under National Institutes of Health.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.